• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.

作者信息

Metzger U, Mermillod B, Aeberhard P, Gloor F, Bissat A, Egeli R, Laffer U, Martinoli S, Mueller W, Schroeder R

出版信息

World J Surg. 1987 Aug;11(4):452-8. doi: 10.1007/BF01655809.

DOI:10.1007/BF01655809
PMID:3114965
Abstract
摘要

相似文献

1
Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.门静脉内化疗作为结直肠癌的一种辅助治疗方式。
World J Surg. 1987 Aug;11(4):452-8. doi: 10.1007/BF01655809.
2
Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.氟尿嘧啶、丝裂霉素和肝素辅助门静脉肝灌注的血液学毒性。
Anticancer Res. 1991 Jan-Feb;11(1):365-8.
3
Adjuvant portal infusion chemotherapy in colorectal cancer.结直肠癌的辅助门静脉灌注化疗
Recent Results Cancer Res. 1988;110:95-100. doi: 10.1007/978-3-642-83293-2_13.
4
[Concepts in the prevention and treatment of liver metastases of colorectal cancer by regional chemotherapy].
Chirurg. 1988 Jan;59(1):34-40.
5
Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
Recent Results Cancer Res. 1986;100:157-62. doi: 10.1007/978-3-642-82635-1_20.
6
[Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].5-氟尿嘧啶（5-FU）和丝裂霉素C（MMC）对结直肠癌肝转移的动脉内化疗
Helv Chir Acta. 1987 Dec;54(4):383-6.
7
Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).结直肠癌辅助门静脉内化疗单疗程的长期结果。瑞士临床癌症研究组（SAKK）。
Lancet. 1995 Feb 11;345(8946):349-53.
8
[Intra-portal chemoprevention and therapy of liver metastases].[门静脉内化学预防及肝转移瘤治疗]
Z Gastroenterol Verh. 1989 Jul;24:189-91.
9
Adjuvant chemotherapy for colon and rectal cancer.结肠癌和直肠癌的辅助化疗。
Semin Oncol. 1995 Oct;22(5):472-87.
10
[Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer].
Gan To Kagaku Ryoho. 1998 Apr;25(5):697-703.

引用本文的文献

1
Adjuvant therapy for completely resected stage II colon cancer.完全切除的II期结肠癌的辅助治疗。
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD005390. doi: 10.1002/14651858.CD005390.pub2.
2
Adjuvant chemotherapy for colorectal cancer.
Curr Gastroenterol Rep. 2002 Oct;4(5):420-6. doi: 10.1007/s11894-002-0013-3.
3
Suppressive effect of doxorubicin on liver recurrence after resection of colonic VX2 cancer lesions: difference in efficacy according to the injection protocol.
Surg Today. 1993;23(6):514-20. doi: 10.1007/BF00730627.
4

本文引用的文献

1
THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM.结肠癌和直肠癌的自然病史。
Am J Surg. 1964 Dec;108:826-9. doi: 10.1016/0002-9610(64)90041-8.
2
METASTASIS OF CANCER OF THE RECTUM AND SIGMOID FLEXURE.直肠癌和乙状结肠癌的转移
Dis Colon Rectum. 1964 Jul-Aug;7:273-7. doi: 10.1007/BF02630531.
3
Clinical significance of cancer cells in the circulating blood: two- to five-year survival.循环血液中癌细胞的临床意义：2至5年生存率
The significance of portal vein chemotherapy for liver micrometastases: an experimental study of a rat model.门静脉化疗对肝微转移的意义：大鼠模型的实验研究
Surg Today. 1994;24(10):900-5. doi: 10.1007/BF01651006.
5
AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.AXIS——一个适合治疗的病例。英国癌症研究协调委员会（UKCCCR）结直肠癌小组委员会。
Br J Cancer. 1991 Jun;63(6):841-5. doi: 10.1038/bjc.1991.187.
6
Adjuvant therapy for cancer of the colon.结肠癌的辅助治疗。
BMJ. 1991 May 11;302(6785):1100-1. doi: 10.1136/bmj.302.6785.1100.
Ann Surg. 1961 Sep;154(3):362-71. doi: 10.1097/00000658-196109000-00006.
4
Discussion on major surgery in carcinoma of the rectum with or without colostomy, excluding the anal canal and including the rectosigmoid: general results of surgical treatment.关于直肠癌伴或不伴结肠造口术的大手术的讨论，不包括肛管，包括直肠乙状结肠：手术治疗的总体结果
Proc R Soc Med. 1957 Dec;50(12):1031-5. doi: 10.1177/003591575705001212.
5
The prophylactic treatment of cancer at the time of operation.手术时癌症的预防性治疗。
Ann Surg. 1957 Oct;146(4):588-93; discussion 593-5. doi: 10.1097/00000658-195710000-00006.
6
The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma.结直肠癌患者肠系膜静脉血中肿瘤细胞的细胞学显示及其意义
Surg Gynecol Obstet. 1955 Jan;100(1):102-8.
7
Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.原发性肿瘤切除与化疗之间的间隔时间对转移灶动力学及生长的影响。
Cancer Res. 1983 Apr;43(4):1488-92.
8
The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer.詹姆斯·尤因讲座。肿瘤体积与化疗耐药性的关系。对癌症手术辅助治疗的启示。
Cancer. 1983 Apr 1;51(7):1209-20. doi: 10.1002/1097-0142(19830401)51:7<1209::aid-cncr2820510707>3.0.co;2-j.
9
Adjuvant therapy of colon cancer--results of a prospectively randomized trial.
N Engl J Med. 1984 Mar 22;310(12):737-43. doi: 10.1056/NEJM198403223101201.
10
Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
Cancer. 1984 Jan 1;53(1):1-8. doi: 10.1002/1097-0142(19840101)53:1<1::aid-cncr2820530102>3.0.co;2-l.